Results of a small but unique research study suggest that low-dose ketamine is generally safe, well-tolerated and effective to treat clinical symptoms in children diagnosed with ADNP syndrome (also known as Helsmoortel-VanDerAa syndrome), a rare neurodevelopmental disorder caused by mutations in the activity dependent neuroprotective protein (ADNP) gene.
Click here for original story, Ketamine may be an effective treatment for children with ADNP syndrome, new study suggests
Source: ScienceDaily